BiotechTube
Home/Mereo BioPharma/Christine Fox
CF

Christine Fox

Chief Financial Officer

Mereo BioPharma

Therapeutic Areas

Rare DiseasesGenetic Disorders

Mereo BioPharma Pipeline

DrugIndicationPhase
Setrusumab (UX-143)Osteogenesis ImperfectaPhase 3
Alvelestat (MPH966)Alpha-1 Antitrypsin Deficiency-associated Lung DiseasePhase 2
Etigilimab (MPH313)Advanced Solid TumorsPhase 1b
Leflutrozole (MPH-220)Hypogonadotropic HypogonadismPhase 2b

Leadership Team at Mereo BioPharma

DD
Dr. Denise Scots-Knight
Chief Executive Officer
CS
Charles Sermon
General Counsel and Business Development
View full Mereo BioPharma profile